Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.

RCMI Coordinating Center (RCMI CC)

Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.

Samanta PN, Kar S, Leszczynski J. Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors. Curr Pharm Des. 2019; 25(7):750-773.

View in: PubMed

subject areas

Computer-Aided Design
Drug Design
Ligands
Molecular Dynamics Simulation
Protein Binding
Quantitative Structure-Activity Relationship
Receptors, Purinergic P1

authors with profiles

Jerzy Leszczynski

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support